United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 24, 2007
IMS HEALTH INCORPORATED
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 001-14049 06-1506026
- ---------------- ----------------------- --------------------------------
(State or other (Commission File Number) IRS Employer Identification No.)
jurisdiction of
incorporation)
1499 Post Road, Fairfield, Connecticut 06824
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (203) 319-4700
Not Applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
|_| Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
- --------------------------------------------------------------------------------
Item 5.02 Departure of Directors or Principal Officers; Election of
Directors; Appointment of Principal Officers; Compensatory
Arrangements of Certain Officers
On January 24, 2007, IMS Health Incorporated (the "Company") announced
that its Board of Directors had appointed Gilles V.J. Pajot to the position of
Executive Vice President and Chief Operating Officer of the Company. This
appointment was made on January 18, 2007. Mr. Pajot was previously the Company's
Executive Vice President and President, Global Business Management. The Company
also announced that its Board of Directors had appointed Leslye G. Katz, the
Company's Vice President and Controller, to the position of Senior Vice
President and Chief Financial Officer. This appointment was made on January 22,
2007. The press release announcing these appointments is attached as Exhibit
99.1 and is incorporated herein by reference.
On January 22, 2007, the Company's Board of Directors also appointed
Harshan Bhangdia to the position of Vice President and Controller of the
Company.
Mr. Pajot, age 57, has served as Executive Vice President and
President, Global Business Management of the Company since January 2006. From
November 2000 until January 2006, Mr. Pajot was Executive Vice President and
President, IMS Europe, Middle East and Africa. He joined the Company as
President of IMS European Region in December 1997. Previously, Mr. Pajot worked
for 20 years with Pharmacia & Upjohn and its predecessor company, serving as
Senior Vice President at Pharmacia & Upjohn from July 1997 to December 1997,
with responsibility for global restructuring initiatives following the 1995
merger of Pharmacia & Upjohn. From November 1995 to July 1997, he was Senior
Vice President of Pharmacia & Upjohn's Europe, Middle East and Africa Region.
Prior to that, he served as Executive Vice President, Worldwide Pharmacia AB
from September 1994 to November 1995.
Ms. Katz, age 52, has served as Vice President and Controller of the
Company since October 2001. Prior to that, from September 1998 to July 2001, Ms.
Katz served as Vice President and Chief Financial Officer of American Lawyer
Media, Inc., a legal journalism and information company. She was Vice President
and Treasurer of Cognizant Corporation from August 1996 to August 1998. Ms. Katz
held a number of senior financial management positions at Dun & Bradstreet
Corporation from 1980 to 1996.
Mr. Bhangdia, age 41, has served as Vice President, Finance, Global
Consulting and Services of the Company since February 2006. From December 2001
to February 2006, Mr. Bhangdia served as the Company's Assistant Controller.
Before joining IMS, Mr. Bhangdia was with Juno Online Services, Inc., an
Internet Service Provider, from September 1999 to November 2001, where he rose
to the position of Senior Vice President and Chief Financial Officer. From
September 1994 to September 1999, Mr. Bhangdia was a senior staff member and
later a manager at PricewaterhouseCoopers LLP. From September 1990 to September
1994, he was a member of the audit staff of the accounting firm Anchin, Block
and Anchin.
2
In connection with her appointment to the position of Senior Vice
President and Chief Financial Officer, the Human Resources Committee of the
Company's Board of Directors recommended, and the Board of Directors approved,
an increase in Ms. Katz's base salary from $315,000 to $375,000 and in her
target annual incentive from $166,000 to $200,000. Additional information
regarding any new or amended employment or compensation agreements or
arrangements with Ms. Katz and Messrs. Pajot and Bhangdia is not available at
this time.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99.1 Press Release issued by IMS Health Incorporated, dated
January 24, 2007.
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IMS HEALTH INCORPORATED
Date: January 24 , 2007 By: /s/ Robert H. Steinfeld
------------------------------------
Robert H. Steinfeld
Senior Vice President, General
Counsel and Corporate Secretary
4
EXHIBIT INDEX
Exhibit 99.1 Press Release issued by IMS Health Incorporated, dated
January 24, 2007.
5